How to Master the Pharmacovigilance System Master File for Inspection Readiness

Blog Details

Pharmacovigilance (PV) inspection outcomes are often shaped before the opening meeting begins. Inspectors typically form an early view of PV systems from the first document they review: the Pharmacovigilance System Master File (PSMF). Providing inspectors with a high-quality PSMF signals strong governance and oversight. Providing a weak or outdated document often guides where inspectors probe.

What Is the Pharmacovigilance System Master File?

In the EU, the UK, and many other regions, the PSMF is a legally required document describing the Marketing Authorisation Holder’s (MAH) PV system. In the EU and UK, it is described in the Good Pharmacovigilance Practice (GVP) Module II (EU) and the MHRA modifications and exceptions to GVP II (UK). Other territories will have their own analog Systems of GVP, with the requirements being very similar to the EU. The GVP II sets expectations for what must be included but does not prescribe a structured template. This allowance for interpretation means PSMFs can appear different but should all provide roughly the same information, giving inspectors a clear and comprehensive overview. Adjacent to the PSMF is the logbook, included in Annex I. This provides an overview of changes to both the PSMF and the PV system.

How are Inspection Notifications Different in the EEA Versus the UK?

In the European Economic Area (EEA), PV inspections are performed by the 30 national inspectorates. It is common in the EEA for the PSMF to be requested at the same time as the inspection is announced.

In the UK, the MHRA is the sole authority performing GVP inspections. The MHRA inspectors often request the PSMF before the inspection is formally announced. While timing varies, the key takeaway is that a PSMF request is an early signal that an inspection request will follow.

What Is the 7‑day Request?

When an inspectorate requests the PSMF, MAHs are granted 7 days to provide an up-to-date copy. Upon receipt of the request, teams set a “data lock point” and must submit a PSMF reflecting the PV system as it exists on that date.

This is where problems can begin. The 7‑day request is independent of routine PSMF update cycles. Even if a routine update was completed recently, the submitted PSMF still needs to be accurate to the data lock point. Pharmacovigilance teams can end up patching gaps under pressure, and if no clear process exists the risk of creating inconsistencies and omitting new information increases.

The Inspection Experience of a Global PV Consultancy

A review of 13 routine inspections over five years (11 full system inspections and two Reference Safety Information/Risk Minimisation Measurements inspections) identified 100 findings in total: 4 critical, 45 major, and 51 minor. Ten findings (10%) were directly PSMF specific (where the PSMF itself caused the finding) and most of those were major (7 major; 3 minor).

The PSMF also featured in roughly one-third of all findings when counting any finding that mentioned or impacted it (in the narrative, root cause, Corrective and Preventive Action (CAPA), or deliverables). In this set, the PSMF was referenced in 25% of critical findings and 40% of major findings, reinforcing a practical point: PSMF issues are frequently treated as system-level weaknesses and tend to be graded as major.

Baghdad, IQ
Nov 20, 2026
weather image
15
°C
few clouds

Contact Info

Baghdad, Iraq / Arasat Al Hindiya, Z.925, St.13, H. 18/2/1

Cart (0 items)
Toggle Dark Mode
Select the fields to be shown. Others will be hidden. Drag and drop to rearrange the order.
  • Image
  • SKU
  • Rating
  • Price
  • Stock
  • Availability
  • Add to cart
  • Description
  • Content
  • Weight
  • Dimensions
  • Additional information
Click outside to hide the comparison bar
Compare